Click here for a description of the charts and data table
Please tell us if you are using this feature and what you think!
| ChEMBL ligand: CHEMBL3221188 |
|---|
There should be some charts here, you may need to enable JavaScript!
|
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
| DB | Assay description | Assay Type | Standard value | Standard parameter | Original value | Original units | Original parameter | Reference |
|---|---|---|---|---|---|---|---|---|
| CB1 receptor/Cannabinoid receptor 1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL218] [GtoPdb: 56] [UniProtKB: P21554] | ||||||||
| ChEMBL | Displacement of [3H]CP55,940 from human recombinant CB1 receptor expressed in CHO-K1 cells | B | 5 | pKi | >10000 | nM | Ki | Medchemcomm (2014) 5: 632-649 |
| CB1 receptor/Cannabinoid receptor 1 in Rat (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3571] [GtoPdb: 56] [UniProtKB: P20272] | ||||||||
| ChEMBL | Displacement of [3H]CP55,940 from CB1 receptor in rat brain cortical membranes | B | 5.08 | pKi | 8240 | nM | Ki | Medchemcomm (2014) 5: 632-649 |
| CB2 receptor/Cannabinoid receptor 2 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL253] [GtoPdb: 57] [UniProtKB: P34972] | ||||||||
| GtoPdb | - | - | 5.39 | pKi | 4030 | nM | Ki | Eur J Med Chem (2018) 155: 381-397 [PMID:29902723] |
| ChEMBL | Displacement of [3H]CP55,940 from human recombinant CB2 receptor expressed in HEK293 cells | B | 5.39 | pKi | 4030 | nM | Ki | Medchemcomm (2014) 5: 632-649 |
| GPR35/G-protein coupled receptor 35 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1293267] [GtoPdb: 102] [UniProtKB: Q9HC97] | ||||||||
| ChEMBL | Antagonist activity at human GPR35 assessed as reduction of zaprinast-induced beta-arrestin recruitment by beta-galactosidase enzyme fragment complementation method | B | 5 | pIC50 | >10000 | nM | IC50 | Medchemcomm (2014) 5: 632-649 |
| ChEMBL | Agonist activity at human GPR35 assessed as induction of beta-arrestin recruitment by beta-galactosidase enzyme fragment complementation method | B | 5 | pEC50 | >10000 | nM | EC50 | Medchemcomm (2014) 5: 632-649 |
| GPR55/G-protein coupled receptor 55 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1075322] [GtoPdb: 109] [UniProtKB: Q9Y2T6] | ||||||||
| ChEMBL | Antagonist activity against human GPR55 expressed in CHO cells assessed as reduction in LPI-induced beta-arrestin recruitment by beta-galactosidase enzyme fragment complementation method | B | 5 | pIC50 | >10000 | nM | IC50 | Medchemcomm (2014) 5: 632-649 |
| GPR18/N-arachidonyl glycine receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2384898] [GtoPdb: 89] [UniProtKB: Q14330] | ||||||||
| GtoPdb | Measuring inhibition of β-arrestin recruitment by tetrahydrocannabinol (THC)-activated human GPR18 | - | 6.55 | pIC50 | 279 | nM | IC50 | Eur J Med Chem (2018) 155: 381-397 [PMID:29902723] |
| ChEMBL | Antagonist activity against human GPR18 expressed in CHO cells assessed as reduction in delta9-THC-induced beta-arrestin recruitment by beta-galactosidase enzyme fragment complementation method | B | 6.55 | pIC50 | 279 | nM | IC50 | Medchemcomm (2014) 5: 632-649 |
ChEMBL data shown on this page come from version 37:
Zdrazil B, Felix E, Hunter F, Manners EJ, Blackshaw J, Corbett S, de Veij M, Ioannidis H, Lopez DM, Mosquera JF, Magarinos MP, Bosc N, Arcila R, Kizilören T, Gaulton A, Bento AP, Adasme MF, Monecke P, Landrum GA, Leach AR. (2024). The ChEMBL Database in 2023: a drug discovery platform spanning multiple bioactivity data types and time periods. Nucleic Acids Res., 52(D1). DOI: 10.1093/nar/gkad1004. [EPMCID:10767899] [PMID:37933841]
Davies M, Nowotka M, Papadatos G, Dedman N, Gaulton A, Atkinson F, Bellis L, Overington JP. (2015) 'ChEMBL web services: streamlining access to drug discovery data and utilities.' Nucleic Acids Res., 43(W1). DOI: 10.1093/nar/gkv352. [EPMCID:25883136]